-

Susan G. Komen® Applauds U.S. Supreme Court Decision Protecting No-cost Access to Lifesaving Breast Care

Court Decision Maintains Insurance Coverage of Screening Mammograms, Genetic Testing, and Medications to Lower Breast Cancer Risk with No Patient Cost

WASHINGTON--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, commends the United States Supreme Court’s decision to overturn a lower court decision that threatened access to preventive breast care services, including screening mammography, risk-reducing medications for high-risk individuals, and genetic counseling and testing for some with a personal or family history of breast or related cancers.

The ruling in Braidwood Management, Inc., et al v. Robert Kennedy, Jr., et al upholds the Affordable Care Act’s (ACA) requirement that insurers cover services without cost-sharing that receive an A or B rating from the United States Preventive Services Taskforce (USPSTF), a decision Komen hailed as a life-saving victory for millions of Americans.

“This decision is a monumental win for public health and a critical safeguard for the 150 million Americans who depend on no-cost preventive care,” Komen stated. “Access to screening mammograms, genetic testing, and risk-reducing medications saves lives. Today, the Court affirmed that everyone deserves a fair chance at early detection and preventive care.”

Komen previously submitted an amicus curiae brief urging the Court to protect ACA provisions that have dramatically improved early detection rates and reduced late-stage breast cancer diagnoses.

“This landmark decision gives those affected by breast cancer the support and care they need in order to continue lowering mortality rates across the U.S.,” Komen continued. “We know breast cancer is most treatable when caught early. Today’s decision helps keep hope alive. We thank the Court for recognizing that preventive care is not a luxury—it is a necessity.”

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

Contacts

Media Contact:
press@komen.org

Susan G. Komen


Release Versions

Contacts

Media Contact:
press@komen.org

More News From Susan G. Komen

Susan G. Komen® to Deliver Urgent Message at Second Annual October Party in Pink Event: “Ending Deaths from Breast Cancer is Within Our Grasp; Together We Will Make it Happen”

NEW YORK--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, is doubling down on its mission “to end deaths from breast cancer” and rallying supporters at its second annual Party in Pink in NYC on October 14th. The event is Komen’s largest opportunity for corporate leaders and philanthropists to commit critical support for people facing breast cancer today and in the future.This year alone, an estimated 321,910 women and 2,670 men in the U.S. will be diagnosed with...

Susan G. Komen® Applauds U.S. House Passage of Legislation That Will Make Breast Health Services More Accessible

WASHINGTON--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, commends members of the U.S. House of Representatives for passing H.R.4541, the EARLY Act Reauthorization of 2025. In addition to the important work of the EARLY Act, the bill included language from the SCREENS for Cancer Act to reauthorize the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). The bill now awaits action by the U.S. Senate and Presidential signature before it can be...

Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, today awarded $15.4 million in grants to cutting-edge breast cancer researchers who are bringing us closer to the cures for all breast cancers. The funded projects span some of the most promising areas of research, including the use of artificial intelligence for better health outcomes and vaccine-based approaches targeting the most aggressive and deadliest forms of breast cancer. In total, 35 researchers...
Back to Newsroom